医药与保健Issue(4)：59-59,66,2.
米非司酮与安宫黄体酮治疗围绝经期功血的疗效观察
Clinical Effect Observation of Mifepristone and Medroxyprogesterone Acetate for Treatment of Perimenopausal Uterine Bleeding
摘要
Abstract
Objective To discuss the clinical effect of mifepristone and medroxyprogesterone acetate for treatment of perim enopausal uterine bleeding.Methods 64 patients received diagnostic curettage during March 2011 to August 2013 were chosen and randomly divided into experiment group and control group each with 32 cases.Experiment group was treated with mifepristone while control group was treated with medroxyprogesterone acetate.Endom etrialthickness and sex horm one changesduring medication and after medication of the 2 groups were com pared.Result After medication,both groups attained certain clinical effects, effective rate of mifepristone was 93.75%obviously higher than medroxyprogesterone acetate 68.75% (P<0.05);mifepristone was superior to medroxyprogesterone acetate on control of endom etrial thickness (P<0.05).Conclusion Mifepristone has a better clinical effect than medroxyprogesterone acetate on treating perim enopausaluterine bleeding and is worth of being popularized clinically.关键词
米非司酮/安宫黄体酮/对比疗效Key words
Mifepristone/Medroxyprogesterone Acetate/Comparison of Clinical Effect分类
医药卫生引用本文复制引用
魏友香,王玉珍..米非司酮与安宫黄体酮治疗围绝经期功血的疗效观察[J].医药与保健,2014,(4):59-59,66,2.
